Holen Sie sich die Stockscreener-App
5.67
1.18%
0.066
Schlusskurs vom Vortag:
$5.604
Offen:
$5.8
24-Stunden-Volumen:
6,910
Relative Volume:
0.01
Marktkapitalisierung:
$5.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.77M
KGV:
-0.00431
EPS:
-1316.2474
Netto-Cashflow:
$-14.37M
1W Leistung:
-4.06%
1M Leistung:
+1.61%
6M Leistung:
+3,655%
1J Leistung:
+5.00%
1-Tages-Spanne:
$5.60
$5.8617
1-Wochen-Bereich:
$5.55
$6.17
52-Wochen-Spanne:
$0.0927
$15.90
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Vergleichen Sie GCTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
5.61 | 5.10M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
560.79 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.15 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.97 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
246.74 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.88 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
GlucoTrack Inc. (GCTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How supply chain issues affect GlucoTrack Inc. stockMarket Weekly Review & Verified Chart Pattern Trade Signals - Newser
Why GlucoTrack Inc. stock remains on watchlistsJuly 2025 Outlook & Daily Chart Pattern Signals - Newser
GlucoTrack (GCTK) Stock Analysis Report | Financials & Insights - Benzinga
GlucoTrack (NASDAQ:GCTK) Stock Price Down 7.5% – Here’s What Happened - Defense World
Head to Head Review: biote (NASDAQ:BTMD) vs. GlucoTrack (NASDAQ:GCTK) - Defense World
GlucoTrack Inc Stock Analysis and ForecastCup and Handle Formations & Superior Capital Growth - earlytimes.in
ASHFORD HOSPITALITY TRUST, INC. (AHT) - MSN
Glucotrack Reports Q3 2025 Results and Strategic Progress - MSN
What analysts say about GlucoTrack Inc stockMid Cap Growth Trends & Market Crushing Stock Picks - earlytimes.in
Is GlucoTrack Inc. stock recession proof2025 Big Picture & Long-Term Capital Growth Ideas - newser.com
What analyst consensus says on GlucoTrack Inc. stockDividend Hike & Weekly Consistent Profit Watchlists - newser.com
GCTK SEC FilingsGlucotrack 10-K, 10-Q, 8-K Forms - Stock Titan
Is GlucoTrack Inc. stock gaining market shareWeekly Profit Summary & Consistent Return Investment Signals - newser.com
Can GlucoTrack Inc. stock outperform in 2025 bull market2025 Dividend Review & Community Shared Stock Ideas - newser.com
How GlucoTrack Inc. stock reacts to bond yieldsJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
How interest rate cuts could boost GlucoTrack Inc. stockQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Can GlucoTrack Inc. stock resist sector downturns2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
Does GlucoTrack Inc. stock trade at a discount to peersDay Trade & Free Weekly Watchlist of Top Performers - newser.com
How GlucoTrack Inc. stock reacts to job market dataPortfolio Gains Report & Consistent Income Trade Ideas - newser.com
Published on: 2025-11-15 02:03:37 - newser.com
Why GlucoTrack Inc. stock could benefit from AI revolutionJuly 2025 Chart Watch & Free Safe Capital Growth Stock Tips - Fundação Cultural do Pará
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - The Manila Times
GlucoTrack Inc. stock daily chart insightsTrade Performance Summary & Smart Swing Trading Techniques - newser.com
[8-K] Glucotrack, Inc. Reports Material Event | GCTK SEC FilingForm 8-K - Stock Titan
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Glucotrack, Inc. Quarterly Earnings Report | GCTK SEC FilingForm 10-Q - Stock Titan
Glucotrack (NASDAQ: GCTK) plans IDE submission Spring 2026, $7.9M cash to support trials - Stock Titan
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):